AGENbenzinga

Agenus Enters Into Asset Purchase Agreement With Zydus Pharmaceuticals, Sells Manufacturing Operations To Zydus Pharmaceuticals For Up To $125M

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 4, 2025 by benzinga